Home > Signal Pathway > TGF-beta/Smad > Bcr-Abl

Bcr-Abl


The Philadelphia chromosome or Philadelphia translocation is a specific genetic abnormality in chromosome 22 of leukemia cancer cells (particularly chronic myelogenous leukemia (CML) cells). This chromosome is defective and unusually short because of reciprocal translocation of genetic material between chromosome 9 and chromosome 22, and contains a fusion gene called BCR-ABL1.

  • Ponatinib EY0427

    Ponatinib (AP24534)是一种新型有效的作用于Abl， PDGFRα， VEGFR2， FGFR1和Src的多靶点抑制剂， IC50分别为0.37 nM， 1.1 nM， 1.5 nM， 2.2 nM和5.4 nM。

    More

  • GNF-5 EY1660

    GNF-5是GNF-2的类似物，具有更好的药物动力学活性，是非ATP竞争性的Bcr-Abl抑制剂，IC50为0.22uM。

    More

  • Bafetinib EY0993

    Bafetinib (INNO-406)是一种有效的，选择性的，Bcr-Abl/Lyn双重抑制剂，IC50为5.8 nM/19 nM，对T315I突变型的磷酸化没有抑制作用，对PDGFR和c-Kit的作用效果稍弱。

    More
    • Current page3, Total Pages3, Total Record13 First Prev 123 Next Last Goto
More